C07C 255/03
Mononitriles
C07C255/03 (Mononitriles) appears on 42 US grants and 50 published applications in this corpus.
Search patents in C07C- Granted patents
- 42
- Published applications
- 50
- Assignees
- 37
- Inventors
- 133
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 2 | 2 |
| 2005 | 0 | 0 |
| 2006 | 2 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 3 |
| 2011 | 0 | 1 |
| 2012 | 1 | 1 |
| 2013 | 3 | 2 |
| 2014 | 0 | 2 |
| 2015 | 4 | 7 |
| 2016 | 4 | 1 |
| 2017 | 0 | 2 |
| 2018 | 2 | 4 |
| 2019 | 3 | 3 |
| 2020 | 1 | 2 |
| 2021 | 2 | 2 |
| 2022 | 3 | 7 |
| 2023 | 3 | 2 |
| 2024 | 2 | 1 |
| 2025 | 3 | 3 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Acetonitrile separation process4 Nov 2025US 12,459,887 B2Ascend Performance Materials Operations LLC
- Bis(fluorosulfonyl)imide compound and method for producing same3 Jun 2025US 12,319,571 B2Nippon Shokubai Co., Ltd.
- Covalent inhibitors of coronavirus papain-like protease25 Feb 2025US 12,234,202 B2UT-Battelle, LLC
- Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole13 Aug 2024US 12,060,382 B2Takeda Pharmaceutical Company Limited
- Acetonitrile separation process7 May 2024US 11,976,025 B2Ascend Performance Materials Operations LLC
- Catalyst, method for producing catalyst, and method for producing acrylonitrile20 Aug 2026US 2026/0241372 A1Asahi Kasei Kabushiki Kaisha
- Electrolyte, secondary battery, and electric device15 Jan 2026US 2026/0018672 A1Contemporary Amperex Technology Co., Limited
- Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 beta-l-ribofuranosyl)1h-benzimidazole8 May 2025US 2025/0145653 A1Takeda Pharmaceutical Company Limited
- Substituted (1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders6 Mar 2025US 2025/0074874 A1Arena Pharmaceuticals, Inc.
- Process for recovering an acetonitrile20 Feb 2025US 2025/0059133 A1De Neef Chemical Processing NV
Most cited
By later US patents
- Hydrocyanation of diolefins and isomerization of nonconjugated 2-alkyl-3-monoalkenenitriles30US 6,020,516 AE. I. Du Pont de Nemours and Company · 2000
- Hydrocyanation of diolefins and isomerization of nonconjugated 2-aklyl-3-monoalkenenitriles19US 6,171,997 B2E. I. Du Pont de Nemours and Company · 2001
- Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders17US 8,580,841 B2Arena Pharmaceuticals, Inc. · 2013
- Purification and recovery of acetonitrile16US 6,326,508 B1The Standard Oil Company · 2001
- Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders15US 9,126,932 B2Arena Pharmaceuticals, Inc. · 2015